Home / Inspections / 1024072

FDA Inspection 1024072 — Baxter Healthcare Corporation

Baxter Healthcare Corporation — FEI 1416980

The FDA completed an inspection of Baxter Healthcare Corporation on July 14, 2017 in Round Lake, IL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 14, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Round Lake, IL (United States)

Facility

Other inspections at this facility

  • 1311078 (OAI Thu Apr 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1243362 (OAI Thu Aug 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1215194 (VAI Fri Aug 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1007331 (NAI Wed Mar 08 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 996518 (NAI Thu Dec 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources